DOLFENAL Mefenamic Acid 250mg Film-Coated Tablet 100's
NONRXDRUG-DRP-8716
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications
Mild to moderate pain; Primary dysmenorrhea.
Dosage
Alternatively, initiate at 500 mg, followed by 250 mg 6 hourly as necessary, usually not more than 1 week. Use the lowest effective dose for the shortest possible duration.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to mefenamic acid; history of hypersensitivity reaction (e.g. asthma, rhinitis, angioedema, urticaria) to aspirin or other NSAIDs. Inflammatory bowel disease, history of gastrointestinal bleeding or perforation related to previous NSAID therapy, active gastrointestinal ulceration or bleeding, history of recurrent peptic ulcer disease or haemorrhage (≥2 distinct episodes of proven ulceration or bleeding), severe heart failure. Use in the setting of CABG surgery. Severe renal and hepatic impairment. Pregnancy (3rd trimester).
Special Precautions
Patient with risk factors for CV disease (e.g. hyperlipidaemia, diabetes mellitus, smoking), hypertension, CHF, established ischaemic heart disease, peripheral arterial disease, cerebrovascular disease, other forms of asthma, oedema, coagulation disorder, intracranial haemorrhage, history of ulcer (particularly if complicated with haemorrhage or perforation), SLE, mixed connective tissue disorder, epilepsy, hypovolaemia. Patient undergoing surgery or dental procedures. Dehydrated and debilitated patients. Mild to moderate renal and hepatic impairment. Children and elderly. Pregnancy (1st and 2nd trimester) and lactation.
Storage
Store between 15-30°C.
MedsGo Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Features
Brand
Dolfenal
Full Details
Dosage Strength
250mg
Drug Ingredients
- Mefenamic Acid
Drug Packaging
Film-Coated Tablet 100's
Generic Name
Mefenamic Acid
Dosage Form
Film-Coated Tablet
Registration Number
DRP-8716
Drug Classification
Over-The-Counter (OTC)
Please sign in so that we can notify you about a reply